The human gastrointestinal tract is exposed to a huge variety of microorganisms, either commensal or pathogenic; at this site, a balance between immunity and immune tolerance is required. Intestinal dendritic cells (DCs) control the mechanisms of immune response/tolerance in the gut. In this paper we have identified a peptide (STp) secreted by Lactobacillus plantarum, characterized by the abundance of serine and threonine residues within its sequence. STp is encoded in one of the main extracellular proteins produced by such species, which includes some probiotic strains, and lacks cleavage sites for the major intestinal proteases. When studied in vitro, STp expanded the ongoing production of regulatory IL-10 in human intestinal DCs from healthy controls. STp-primed DC induced an immunoregulatory cytokine profile and skin-homing profile on stimulated T-cells. Our data suggest that some of the molecular dialogue between intestinal bacteria and DCs may be mediated by immunomodulatory peptides, encoded in larger extracellular proteins, secreted by commensal bacteria. These peptides may be used for the development of nutraceutical products for patients with IBD. In addition, this kind of peptides seem to be absent in the gut of inflammatory bowel disease patients, suggesting a potential role as biomarker of gut homeostasis.
References
[1]
Mowat AM (2003) Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 3: 331–341.
[2]
Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245–252.
Hart AL, Lammers K, Brigidi P, Vitali B, Rizzello F, et al. (2004) Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53: 1602–1609.
[5]
Stagg AJ, Hart AL, Knight SC, Kamm MA (2003) The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut 52: 1522–1529.
O’Garra A, Barrat FJ, Castro AG, Vicari A, Hawrylowicz C (2008) Strategies for use of IL-10 or its antagonists in human disease. Immunol Rev 223: 114–131.
[8]
Saraiva M, O’Garra A (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10: 170–181.
[9]
Cerf-Bensussan N, Gaboriau-Routhiau V (2010) The immune system and the gut microbiota: friends or foes?. Nat Rev Immunol 10: 735–744.
[10]
Feng T, Elson CO (2011) Adaptive immunity in the host-microbiota dialog. Muc Immunol 4: 15–21.
[11]
Sansonetti PJ (2011) To be or not to be a pathogen: that is the mucosally relevant question. Muc Immunol 4: 8–14.
[12]
Maloy KJ, Powrie F (2011) Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474: 298–306.
[13]
Gourbeyre P, Denery S, Bodinier M (2011) Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions. J Leukoc Biol 89: 685–695.
[14]
Ng SC, Plamondon S, Al-Hassi HO, English N, Gellatly N, et al. (2009) A novel population of human CD56+human leucocyte antigen D-related (HLA-DR plus) colonic lamina propria cells is associated with inflammation in ulcerative colitis. Clin Exp Immunol 158: 205–218.
[15]
Lebeer S, Vanderleyden J, De Keersmaecker SCJ (2010) Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol 8: 171–184.
[16]
Sánchez B, Bressollier P, Urdaci MC (2008) Exported proteins in probiotic bacteria: adhesion to intestinal surfaces, host immunomodulation and molecular cross-talking with the host FEMS. Immunol Med Mic 54: 1–17.
[17]
Chevallier B, Hubert JC, Kammerer B (1994) Determination of chromosome size and number of rrn loci in Lactobacillus plantarum by pulsed-field gel electrophoresis. FEMS Microbiol Lett 120: 51–56.
[18]
Kleerebezem M, Boekhorst J, van Kranenburg R, Molenaar D, Kuipers OP, et al. (2003) Complete genome sequence of Lactobacillus plantarum WCFS1. Proc Nat Acad Sci USA 100: 1990–1995.
[19]
Tallon R, Arias S, Bressollier P, Urdaci MC (2007) Strain- and matrix-dependent adhesion of Lactobacillus plantarum is mediated by proteinaceous bacterial compounds. J Appl Microbiol 102: 442–451.
[20]
de Vries MC, Vaughan EE, Kleerebezem M, de Vos WM (2006) Lactobacillus plantarum: survival, functional and potential probiotic properties in the human intestinal tract. Int Dairy J 16: 1018–1028.
[21]
Molin G (2001) Probiotics in foods not containing milk or milk constituents, with special reference to Lactobacillus plantarum 299 v. Am J Clin Nutr 73: 380s–385s.
[22]
van Baarlen P, Troost FJ, van Hemert S, van der Meer C, de Vos WM, et al. (2009) Differential NF-kappa B pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc Nat Acad Sci U S A 106: 2371–2376.
[23]
Beck HC, Madsen SM, Glenting J, Petersen J, Israelsen H, et al. (2009) Proteomic analysis of cell surface-associated proteins from probiotic Lactobacillus plantarum. FEMS Microbiol Lett 297: 61–66.
[24]
Madsen SM, Glenting J, Vrang A, Ravn P, Riemann HK, et al. (2005) Cell surface-associated glycolytic enzymes from Lactobacillus plantarum 299v mediate adhesion to human epithelial cells and extracellular matrix proteins. J Biotechnol 118: S142–S142.
[25]
Sánchez B, Schmitter JM, Urdaci MC (2009) Identification of novel proteins secreted by Lactobacillus plantarum that bind to mucin and fibronectin. J Mol Microbiol Biotechnol 17: 158–162.
[26]
Siboo IR, Chambers HF, Sullam PM (2005) Role of SraP, a serine-rich surface protein of Staphylococcus aureus, in binding to human platelets. Infect Immun 73: 2273–2280.
[27]
Kankainen M, Paulin L, Tynkkynen S, von Ossowski I Reunanen J, et al. (2009) Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human-mucus binding protein. Proc Nat Acad Sci U S A 106: 17193–17198.
[28]
Hart AL, Al-Hassi HO, Rigby RJ, Bell SJ, Emmanuel AV, et al. (2005) Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 129: 50–65.
[29]
Mann ER, Bernardo D, Al-Hassi HO, English NR, Clark SK, et al. (2011) Human gut-specific homeostatic dendritic cells are generated from blood precursors by the gut microenvironment Inflamm Bowel Dis. doi:101002/ibd21893.
[30]
Round JL, Lee SM, Li J, Tran G, Jabri B, et al. (2011) The toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332: 974–977.
[31]
Round JL , Mazmanian SK (2010) Inducible Foxp(3+) regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Nat Acad Sci USA 107: 12204–12209.
[32]
Yan F, Cao H, Cover TL, Washington MK, Shi Y, et al. (2011) Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest 121: 2242–2253.
[33]
Macho Fernandez E, Valenti V, Rockel C, Hermann C, Pot B, et al. (2011) Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut 60: 1050–1059.
